Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
divestment
MedTech
J&J reveals plan to spin off its $9B orthopedics business
Two years after spinning off its $15 billion consumer health unit, Johnson & Johnson is unveiling a plan to separate from its orthopedics business.
Kevin Dunleavy
Oct 14, 2025 11:30am
Teleflex buys Biotronic’s vascular catalog, plans company split
Feb 27, 2025 11:00am
BD bids farewell to its diagnostic, bioscience divisions
Feb 6, 2025 1:10pm
RFK Jr. will divest interests in biotechs if HHS role confirmed
Jan 22, 2025 1:37pm
Surgalign sells spinal implant product lines for $17M
Mar 2, 2023 12:58pm
Exact Sciences sells Oncotype prostate cancer test for $30M
Aug 3, 2022 11:37am
